Neural stem cells (NSCs) are capable of self-renewal and differentiation into neurons, astrocytes and oligodendrocytes under specific local microenvironments. In here, we present a set of methods used for three dimensional (3D) differentiation and miRNA analysis of a clonal human neural stem cell (hNSC) line, currently in clinical trials for stroke disability (NCT01151124 and NCT02117635, Clinicaltrials.gov). HNSCs were derived from an ethical approved first trimester human fetal cortex and conditionally immortalized using retroviral integration of a single copy of the c-mycER TAM construct. We describe how to measure axon process outgrowth of hNSCs differentiated on 3D scaffolds and how to quantify associated changes in miRNA expression using PCR array. Furthermore we exemplify computational analysis with the aim of selecting miRNA putative targets. SOX5 and NR4A3 were identified as suitable miRNA putative target of selected significantly down-regulated miRNAs in differentiated hNSC. MiRNA target validation was performed on SOX5 and NR4A3 3'UTRs by dual reporter plasmid transfection and dual luciferase assay.
Introduction
Stem cell research plays a central role in regenerative medicine, which also spans the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, and biomaterials (scaffolds and matrices). Stem cells are important in both organ developmentand tissue repair; understanding how stem cells work is pivotal for developing new stem cell based treatments 1 . CTX0E03 is a clonal, conditionally immortalized human neural stem cell (hNSC) line 2 isolated from first trimester human fetal cortex. CTX0E03 has defined quality characteristics that are essential for clinical cell banking under good manufacturing practice (GMP) 3 . HNSCs can spontaneously differentiate into neurons, glia, and oligodendrocytes and have been proven to ameliorate neurological deficits when transplanted in a rodent model of focal ischemia 2, 4, 5 . The CTX0E03 hNSCs are currently in clinical trials for stroke disability (NCT01151124 6 and NCT02117635, Clinicaltrials.gov).
MiRNAs have an average 22 nucleotides in length and are proven regulatory molecules 7 , they do not encode proteins, but rather bind 3 prime untranslated region (3'UTR) of mRNAs, regulating their stability and translation into proteins. MiRNAs are reported to participate in the regulation of a number of cellular processes, including development, proliferation, and differentiation 8 . Several miRNAs have been implicated in regulating the fate and specification of neural stem cells 9 .
In two dimensional (2D) standard culture environment the complexity of the in vivo environment is not matched, and consequently the induction and regulation of hNSC differentiation is not optimal. In vivo, cells are surrounded by a three dimensional (3D) microenvironment composed by other cells and extracellular ligands, including many types of collagens, laminin, and other matrix proteins (extracellular matrix, ECM). Previous studies have reported that the architectural topography of the materials mimicking ECMs and their geometry influence cell phenotype and fate [10] [11] [12] [13] [14] [15] . A number of commercially available 3D scaffolds are available; we used a highly porous polystyrene scaffold engineered with a welldefined and uniform architecture into a 200 µm thick membrane which provides a 3D space into which cells can invade and differentiate [16] [17] [18] . Herein 2D and 3D differentiation assays are used to assess axonprocess outgrowth. Furthermore, we describe a method to profile the miRNA expression of a clinical grade hNSC line to further investigate miRNA effects on its differentiation. The methods in here illustrated are based on the ones originally described in , online available algorithm for the identification of miRNA target prediction mRNAs. NOTE: PicTar computes a score reflecting the likelihood that a given UTR will be targeted by the selected miRNA, and based on seed complementarity, thermodynamics and a combinatorial prediction for common targets in sets of co-expressed miRNAs 22 . 5. Similarly retrieve list of target mRNAs using DIANA-LAB (http://diana.cslab.ece.ntua.gr/microT/) 23 , and TargetScan (http:// www.targetscan.org/) 24 , alternative on line available algorithms. 6. Compile a comparative table of miRNAs based on ranking obtained using different software tools. PicTar ranks by score, DianaLab by precision (based on signal to noise ratio and a precision score for the evaluation of the significance of the predicted results), and TargetScan by aggregate PCT (based on seed complementarity, thermodynamic free energy of binding, conservation over different species), see Table 1 .
3.2) Validation of Target mRNAs by Reporter Plasmid Transfection and Dual Luciferase Assay.
NOTE: 3' UTR luciferase reporters for the validation of target mRNA has been previously described 25 .
1. Transfection 1. Seed HeLa cells at a density of 10 5 cells/well in 24-well plate.
2. After 24 hr, co-transfect HeLa cells with 1.5 µl of transfection reagent and either 100 ng of NR4A3 3' UTRor SOX5 3' UTR plasmid, as well as 20 nM miRNA mimics (hsa-miR-96-5p for SOX5 3' UTR, and hsa-miR-7-5p, and hsa-miR-17-5p for NR4A3 3' UTR respectively) per well. 3. Co-transfect control wells with NR4A3 3' UTRor SOX5 3' UTRplasmid and fluorochrome labelled negative control siRNAs. The transfection of control wells with fluorochrome labelled negative control siRNAs allows evaluation of transfection efficiency and accounts for mimic miRNA 3'UTR bind specificity. 
Representative Results
In Figure 1 is visualized the investigation and quantification of hNSC differentiation on 3D scaffolds compared with traditional flat surface cultures (2D) and expressedas axon process outgrowth measurements. In Figure 2 is representedthe workflow and the results for the miRNA quantification using stem cells and developmental pathways focused miRNA PCR array to investigate differential expression of miRNAs in 2D and 3D differentiated hNSCs compared with undifferentiated control. Following miRNA comparative analysis between differentiated and undifferentiated hNSCs, and computational analysis for target prediction, SOX5 and NR4A3 (NOR1) were identified as putative target mRNAs.
To study the direct interaction between the miRNAs and their putative site on the 3'UTR mRNA we used 2 commercially available plasmids containing either SOX5 or NR4A3 3′UTR sequence inserted downstream of the firefly luciferase reporter gene, and containing in the same . Please click here to view a larger version of this figure. Table 1 : List of miRNA target prediction mRNAs. Representative table of miRNAs, target predictive genes,and algorithms analysis (prediction/ score/aggregate provided using Diana Lab, PicTar, and TargetScan respectively). Modified from Table 3 19 .
DIANALAB

Discussion
The development of new in vitro assays to assess and improve the differentiation of stem cells has always presented a challenge for the investigation of their functionalities and therapeutic capabilities. Long term and stable attachment of hNSCs, required for the development of a robust 3D in vitro differentiation assay, was addressed by testing several 3D substrates with different characteristics in term of materials and structures. As part of the assay development we also assessed optimal cell seeding concentration and identified the requirement for the scaffolds to be laminin coated. Although our hNSCs can spontaneously differentiate upon 4-OHT and growth factor removal, the implementation of a 3D culture system showed a significant improvement in their differentiation capability as measured by axon process outgrowth when compared to standard 2D differentiated hNSCs.
To investigate the effect of 3D induced differentiation on hNSC miRNA expression we used a PCR array. Compared with standard chip microarray PCR array offers the advantages of a direct quantification and validation of miRNA of interest. Although the PCR array is limited in A single miRNA can recognize hundreds of targets and for this reason we validated miRNA interactions with 3' UTR mRNAsthat may be suitable candidates in axonal regulation. NR4A3, a target of the hsa-miR-7, and miR-17 family, is a member of the NR4A family nuclear receptors which, depending on their level of expression, are involved in the differentiation, survival, apoptosis and regulation of hippocampal axon guidance 26 . Similarly SOX5, a target of hsa-miR-96, is reported to control cell cycle progression in neural progenitors 27 axon length 28 , migration, postmigratory differentiation, and projections of neurons 29 . Both SOX5 and NR4A3 were identified as a direct target mRNA of hsa-miR-96, and hsa-miR-7 and 17 respectively by dual luciferase reporter assays. Dual luciferase (Firefly and Renilla) relies on two different reporter genes in the same plasmid and offers an improved system allowing normalization for effects caused by suboptimal transfection and cytotoxic effects compared with a single luciferase plasmid system. As part of our assay development we also optimized our transfection conditions in order to obtain high efficiency.
The protocolsdescribed herein may be exploited to further optimize and characterize in vitro hNSC differentiation which may beimplemented intransplantation protocols for pre-clinical studies and future clinical applications.
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